Showing results (31-40 of 174) with videos related to
Sort By:
Pageof 18
Clinical Rheumatology|July 1, 1995
Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapyF Salaffi, M Carotti, C CerviniScandinavian Journal of Rheumatology|January 1, 1996
Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritisF Salaffi, M Carotti, C CerviniLa Clinica Terapeutica|January 1, 1993
[The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis]C Cervini, F Salaffi, M PeroniInternational Journal of Clinical Pharmacology Research|January 1, 1994
Intra-articular injection of somatostatin in knee osteoarthritis: clinical results and IGF-1 serum levelsF Silveri, P Morosini, D Brecciaroli, et al.La Clinica Terapeutica|January 1, 1997
[Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis]A Mundo, V Pedone, G Lamanna, et al.The Journal of Rheumatology|October 1, 1994
Serum levels of insulin in overweight patients with osteoarthritis of the kneeF Silveri, D Brecciaroli, F Argentati, et al.Clinical and Experimental Rheumatology|January 1, 1995
A prospective study of the long-term efficacy and toxicity of low-dose methotrexate in rheumatoid arthritisF Salaffi, M Carotti, A Sartini, et al.Pharmacological Research|May 1, 1990
Diacetylrhein and rhein: in vivo and in vitro effect on lymphocyte membrane fluidityE Beccerica, G Ferretti, G Curatola, et al.Pharmacological Research|September 1, 1993
Polymorphonuclear leukocytes activation: in vitro modulation by 6-methoxy-2-naphthylacetic acid, the major active metabolite of nabumetoneA Allegrezza-Giulietti, R Serretti, M Peroni, et al.Reumatismo|December 31, 2005
[Approved indications and other possible utilizations of anti-TNFα biologic drugs]W Grassi, C MontecuccoPageof 18